Abiopharma

🔍 Mehta Vikas (Executive)

Company: ACV Auctions Inc. (ACVA)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 300,300 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 857,276.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,320 shares of Common Stock at $4.27 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 850,956.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 4,487 shares of Common Stock at $4.27 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 846,469.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 6,382 shares of Common Stock at $4.27 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 840,087.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents a restricted stock unit ("RSU") award. The RSUs will vest in twelve (12) substantially equal quarterly installments beginning July 1, 2026, subject to the Reporting Person's continuous service through each such date.
• F2: These shares were withheld by the Issuer to cover the tax liability upon the vesting of a time-based restricted stock unit previously granted, and does not represent a discretionary sale by the reporting person.